CrossCare

ROB-ID

The secondary and tertiary line of care is increasingly shifting from hospitals to general practitioners’ offices and pharmacies. This helps healthcare providers maintain the quality of curative care but simultaneously increases the workload for pharmacists. With this project, Stemberg addresses the medical necessity to vaccinate more people quickly and robotically. In collaboration with the CrossCare living labs, they aim to test a new functional prototype of a ‘vaccination robot’ through co-creation. The company plans to do this together with their target groups: doctors, pharmacists, active adults, and people over 65. These insights help refine the development of the vaccination robot and establish an effective development strategy. Moreover, the interregional collaboration between Flanders and the Netherlands provides valuable knowledge on how automated vaccination can be integrated into future healthcare.

About CrossCare 2.0

The CrossCare project stimulates, supports, and accelerates innovations in healthcare. CrossCare contributes to the development and implementation of healthcare innovations (product, service, concept) by offering a healthcare living lab setting and has a fund to support innovation projects. CrossCare provides an accessible path to realizing healthcare innovation on a larger scale. It is a cross-border project of Interreg Flanders-Netherlands and supports both practically and financially. Because CrossCare has eight healthcare living labs in Flanders and the Netherlands, healthcare innovations can be tested and further developed by end users. Slimmer Leven, together with its members, forms one of the eight healthcare test beds where SMEs can test.

In the first successful CrossCare project (2016-2021), Flemish and Dutch healthcare living labs supported 30 healthcare innovations. On Wednesday, May 17, 2023, INTERREG Flanders-Netherlands approved the successor ‘CrossCare 2.0’. CrossCare 2.0 will continue on the same path over the next three years and will again facilitate the development and implementation of innovations in the healthcare and welfare sector.

On the one hand, companies/healthcare organizations developing innovations can receive financial support from the ‘CrossCare innovation fund’. This support can amount to up to €100,000 per organization. On the other hand, healthcare test beds on both sides of the border also support the selected companies/healthcare organizations by demonstrating/testing/evaluating innovations with end users. The healthcare test beds are experts in co-creation and live testing with healthcare users and professionals in their own living and working environment. They provide this expertise free of charge in this project.